Under Innovation Cell, Metropolis is introducing various specialised tests related to pregnancy, cancer, infectious diseases and transplant management
Metropolis Healthcare has announced the launch of Metropolis Innovation Cell focusing on molecular genomics, superspeciality pathology and companion diagnostics.
It is launhing specialised tests for non-invasive genetic assessments for pregnancy management that can aid in early detection of chromosomal abnormalities. Also, BRCA1/BRCA 2 genetic testing for hereditary breast and Ovarian Cancer (HBOC), and Molecular Oncology pipeline for Lung and common cancers
Commenting on the establishment of Metropolis Innovation Cell, Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Limited said, “As the Innovation and R&D arm of the organisation, Metropolis Innovation Cell will focus on the pursuit of fundamental scientific discoveries to catalyse optimal patient management.”